Jenneken Naaldenberg

Dr. Jenneken Naaldenberg


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in Research in Developmental Disabilities
Verified
Journal Article
Closed access
TFTessa Kim Frankena
Tessa Kim Frankena
JNJenneken Naaldenberg
Jenneken Naaldenberg
MCMieke Cardol
Mieke Cardol
CLChristine Linehan
Christine Linehan
HVHenny van Schrojenstein Lantman-De Valk
Henny van Schrojenstein Lantman-De Valk

2 December 2015 in Journal of Intellectual Disability Research
Verified
Journal Article
Closed access
PDF file
NKN. M. J. Kuijken
N. M. J. Kuijken
JNJenneken Naaldenberg
Jenneken Naaldenberg
RSRia Nijhuis-van der Sanden
Ria Nijhuis-van der Sanden
HVH. M. J. van Schrojenstein‐Lantman de Valk
H. M. J. van Schrojenstein‐Lantman de Valk

17 November 2021 in Cancer
Verified
Journal Article
Open access
PDF file
MCMaarten Cuypers
Maarten Cuypers
BSBianca W. M. Schalk
Bianca W. M. Schalk
ABAnne J. N. Boonman
Anne J. N. Boonman
JNJenneken Naaldenberg
Jenneken Naaldenberg
GLGeraline L. Leusink
Geraline L. Leusink
Background: Concerns have been raised about access to cancer screening and the timely receipt of cancer care for people with an intellectual disability (ID). However, knowledge about cancer mortality as a potential consequence of these disparities is still limited. This study, therefore, compared cancer‐related mortality patterns between people with and without ID.Methods: A historical cohort study (2015‐2019) linked the Dutch adult population (approximately 12 million people with an ID prevalence of 1.45%) and mortality registries. Cancer‐related mortality was identified by the underlying cause of death (according to the chapter on neoplasms in the International Classification of Diseases, Tenth Revision). Observed mortality and calculated age‐ and sex‐standardized mortality ratios (SMRs) with 95% confidence intervals (CIs) were reported.Results: There were 11,102 deaths in the ID population (21.7% cancer‐related; n = 2408) and 730,405 deaths in the general population (31.2%; n = 228,120) available for analysis. Cancer was noted as the cause of death more often among people with ID in comparison with the general population (SMR, 1.48; 95% CI, 1.42‐1.54), particularly in the young age groups. High‐mortality cancers included cancers within the national screening program (SMRs, 1.43‐1.94), digestive cancers (SMRs, 1.24‐2.56), bladder cancer (SMR, 2.07; 95% CI, 1.61‐2.54), and cancers of unknown primary (SMR, 2.48; 95% CI, 2.06‐2.89).Conclusions: Cancer was reported as the cause of death approximately 1.5 times more often in people with ID compared with the general population. This mortality disparity may indicate adverse effects from inequalities in screening and cancer care experienced by people with ID.Lay Summary: People with an intellectual disability (ID) may find it challenging to participate in cancer screening or to receive timely cancer care. To understand potential consequences in terms of mortality, this study compared cancer‐related mortality between people with and without ID in the Netherlands. Cancer was reported as the cause of death approximately 1.5 times more often among people with ID than others. Because large differences were found that were related to screening cancers and cancers for which the primary tumor was unknown, this study's results raise concerns about equality in screening practices and cancer care for people with ID.

1 March 2009 in Global Health Promotion
Verified
Journal Article
Closed access
JNJenneken Naaldenberg
Jenneken Naaldenberg
LVLenneke Vaandrager
Lenneke Vaandrager
MKMaria Koelen
Maria Koelen
Annemarie WagemakersAnnemarie Wagemakers
Annemarie Wagemakers
HSHans Saan
Hans Saan
KHKees de Hoog
Kees de Hoog
Health and well-being are the result of a series of complex processes in which an individual interacts with other people and the environment. A systematic approach ensures incorporation of individual, ecological, social and political factors. However, interactions between these factors can be overlooked within a systematical approach. A systemic approach can provide additional information by incorporating interactions and communication. The opportunities of a systems thinking perspective for health promotion were investigated for this paper. Although others have also made attempts to explore systems thinking in the field of health promotion, the implications of systems thinking in practice need attention. Other fields such as agricultural extension studies, organizational studies and development studies provide useful experiences with the use of a systems thinking perspective in practice. Building on experiences from these fields, we give a theoretical background in which processes of social learning and innovation play an important role. From this background, we derive an overview of important concepts for the practical application of a systems thinking perspective. These concepts are the structure of the system, meanings attached to actions, and power relations between actors. To make these concepts more explicit and reduce the theoretical character of systems thinking, we use an illustration to elaborate on these concepts in practice. For this purpose, we describe a health promotion partnership in The Netherlands using the concepts structure, meaning and power relations. We show how a systems perspective increases insight in the functioning of a partnership and how this can facilitate processes of social learning and innovation. This article concludes by identifying future opportunities and challenges in adopting systems thinking for health promotion practice. A systems perspective towards health promotion can help projects reaching a more integral and sustainable approach in which the complex nature of health promotion processes is supported. Practical applications of systems thinking are necessary to adapt this perspective. (Global Health Promotion, 2009; 16 (1): pp. 39—47)

1 September 2014 in Research in Developmental Disabilities
Verified
Journal Article
Closed access
MMM. Mastebroek
M. Mastebroek
JNJenneken Naaldenberg
Jenneken Naaldenberg
ALA.L. Lagro-Janssen
A.L. Lagro-Janssen
HVH. van Schrojenstein Lantman de Valk
H. van Schrojenstein Lantman de Valk

1 December 2013 in Research in Developmental Disabilities
Verified
Journal Article
Closed access
JNJenneken Naaldenberg
Jenneken Naaldenberg
NKNoortje Kuijken
Noortje Kuijken
KDKate van Dooren
Kate van Dooren
HVHenny van Schrojenstein Lantman de Valk
Henny van Schrojenstein Lantman de Valk